The global demand for Sanger Sequencing Service Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
Sanger sequencing or chain termination method is used for the determination of the nucleotide sequence of DNA. Nobel Laureate Frederick Sanger and his colleagues developed this method in 1977; hence the name Sanger Sequencing is given. Sanger sequencing is performed either manually or in an automated way in three steps, DNA Sequence for Chain Termination PCR, Size Separation by Gel Electrophoresis, and Gel Analysis & Determination of DNA Sequence. It is a targeted sequencing method performed by using oligonucleotide primers to find out specific DNA regions. It is a gold standard DNA sequencing technology that offers excellent accuracy and flexibility. Sanger sequencing is applicable in the identification of many diseases such as diabetes, cancer, mechanism of aging. The sequencing method is used in matching patients and donors in bone marrow and cord blood transplants. It is a powerful diagnostic tool in molecular diagnostics.
The global market for Sanger sequencing service is growing due to technological advancement, increasing awareness about genetic diseases, rising demand for genotyping services, and increased adoption for personalized medicine. Expanding the use of pharmacogenomics in drug discovery and development and increased application of Sanger sequencing in animal and plant DNA analysis are other factors leading to growth of this market.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of sanger sequencing service.
The entire sanger sequencing service market has been sub-categorized into application and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By End User
- Biomarkers & Cancer
- Reproductive Health
- Personalized Medicine
- Academic & Government Research Institutes
- Pharmaceutical Companies
- Biotechnology Companies
- Hospitals & Clinics
This section covers regional segmentation which accentuates on current and future demand for sanger sequencing service market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Europe Sanger Sequencing Service Market By Revenue (USD MN)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the sanger sequencing service market include Source BioScience, GenScript Biotech Corporation, Thermo Fisher Scientific, Inc., LGC Science Group Limited, Fasteris SA, CeMIA SA, Quintara Biosciences, GenHunter Corporation, GENEWIZ, Nucleics, SciGenom Labs Pvt. Limited, Microsynth AG. Inc. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.